Literature DB >> 11123311

A subset of human dendritic cells expresses IgA Fc receptor (CD89), which mediates internalization and activation upon cross-linking by IgA complexes.

F Geissmann1, P Launay, B Pasquier, Y Lepelletier, M Leborgne, A Lehuen, N Brousse, R C Monteiro.   

Abstract

Immature dendritic cells (DC) sample Ags within nonlymphoid tissues and acquire exogenous proteins/pathogens via scavenger receptors or Ig FcR such as Fc gamma R and Fc epsilon R. IgA is present in a significant proportion among serum Ig and is the main isotype in mucosae, where DC are numerous. We found that a functional Fc alpha R (CD89) was expressed in situ and in vitro on interstitial-type DC but not on Langerhans cell-type DC. Interstitial-type DC expressed CD89 as a 50- to 75-kDa glycoprotein with a 32-kDa protein core, which was down-regulated upon addition of TGF-beta 1. DC, Fc alpha R specifically, bound IgA1 and IgA2. Cross-linking of CD89 on DC triggered endocytosis in time-dependent manner. In addition, internalization of polymeric IgA complexes induced the production of IL-10 and DC activation, as reflected by up-regulation of CD86 costimulatory molecules, class II MHC expression, and increased allostimulatory activity. Therefore, interstitial-type DC may use Fc alpha R-mediated Ag sampling in the subepithelium to check tissue integrity while Langerhans cells inside epithelial layers may neglect IgA immune complexes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11123311     DOI: 10.4049/jimmunol.166.1.346

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Ectodomain shedding of Fcalpha receptor is mediated by ADAM10 and ADAM17.

Authors:  Min Peng; Sha Guo; Na Yin; Jing Xue; Lian Shen; Qing Zhao; Wei Zhang
Journal:  Immunology       Date:  2010-01-06       Impact factor: 7.397

Review 2.  Role of IgA and IgA fc receptors in inflammation.

Authors:  Renato C Monteiro
Journal:  J Clin Immunol       Date:  2009-10-16       Impact factor: 8.317

Review 3.  Immunoglobulin A: A next generation of therapeutic antibodies?

Authors:  Jantine E Bakema; Marjolein van Egmond
Journal:  MAbs       Date:  2011-07-01       Impact factor: 5.857

4.  Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells.

Authors:  K Olas; H Butterweck; W Teschner; H P Schwarz; B Reipert
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

5.  Genetic variants of the IgA Fc receptor (FcalphaR, CD89) promoter in chronic hepatitis C patients.

Authors:  Azuma Watanabe; Toshibumi Shimokawa; Mitsuhiko Moriyama; Fumihiko Komine; Shuichi Amaki; Yasuyuki Arakawa; Chisei Ra
Journal:  Immunogenetics       Date:  2006-10-11       Impact factor: 2.846

6.  HIV-1 replication in Langerhans and interstitial dendritic cells is inhibited by neutralizing and Fc-mediated inhibitory antibodies.

Authors:  M Peressin; V Holl; S Schmidt; T Decoville; D Mirisky; A Lederle; M Delaporte; K Xu; A M Aubertin; C Moog
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

7.  Altered expression and endocytic function of CD205 in human dendritic cells, and detection of a CD205-DCL-1 fusion protein upon dendritic cell maturation.

Authors:  Matt Butler; Anne-Sophie Morel; William J Jordan; Efrem Eren; Susan Hue; Rachel E Shrimpton; Mary A Ritter
Journal:  Immunology       Date:  2006-12-08       Impact factor: 7.397

Review 8.  The biology of intestinal immunoglobulin A responses.

Authors:  Andrea Cerutti; Maria Rescigno
Journal:  Immunity       Date:  2008-06       Impact factor: 31.745

Review 9.  Tissues: the unexplored frontier of antibody mediated immunity.

Authors:  Nicholas E Webb; Biana Bernshtein; Galit Alter
Journal:  Curr Opin Virol       Date:  2021-02-10       Impact factor: 7.090

10.  Poly-IgA Complexes and Disease Severity in IgA Nephropathy.

Authors:  Xue Zhang; Jicheng Lv; Pan Liu; Xinfang Xie; Manliu Wang; Dan Liu; Hong Zhang; Jing Jin
Journal:  Clin J Am Soc Nephrol       Date:  2021-10-04       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.